Neurocrine's Crenessity ends 70-year drought with FDA nod for rare genetic disease After seven decades with no advances in the treatment of the genetic disorder classic congenital adrenal hyperplasia (CAH), Neurocrine Biosciences has ... 12/16/2024 - 2:27 am | View Link